Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association
Authors:
- Goutham RaoGRGoutham Rao
- Francisco Lopez-JimenezFLFrancisco Lopez-Jimenez
- Jack BoydJBJack Boyd
- Frank D’aMicoFDFrank D’aMico
- Nefertiti H. DurantNDNefertiti H. Durant
- Mark A. HlatkyMHMark A. Hlatky
- George HowardGHGeorge Howard
- Katherine KirleyKKKatherine Kirley
- Christopher MasiCMChristopher Masi
- Tiffany M. Powell-WileyTPTiffany M. Powell-Wiley
- Anthony E. SolomonidesASAnthony E. Solomonides
- Colin P. WestCWColin P. West
Open Access
- 5 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 136 (10) , e172-e194
Abstract
Meta-analyses are becoming increasingly popular, especially in the fields of cardiovascular disease prevention and treatment. They are often considered to be a reliable source of evidence for making healthcare decisions. Unfortunately, problems among meta-analyses such as the misapplication and misinterpretation of statistical methods and tests are long-standing and widespread. The purposes of this statement are to review key steps in the development of a meta-analysis and to provide recommendations that will be useful for carrying out meta-analyses and for readers and journal editors, who must interpret the findings and gauge methodological quality. To make the statement practical and accessible, detailed descriptions of statistical methods have been omitted. Based on a survey of cardiovascular meta-analyses, published literature on methodology, expert consultation, and consensus among the writing group, key recommendations are provided. Recommendations reinforce several current practices, including protocol registration; comprehensive search strategies; methods for data extraction and abstraction; methods for identifying, measuring, and dealing with heterogeneity; and statistical methods for pooling results. Other practices should be discontinued, including the use of levels of evidence and evidence hierarchies to gauge the value and impact of different study designs (including meta-analyses) and the use of structured tools to assess the quality of studies to be included in a meta-analysis. We also recommend choosing a pooling model for conventional meta-analyses (fixed effect or random effects) on the basis of clinical and methodological similarities among studies to be included, rather than the results of a test for statistical heterogeneity.Keywords
This publication has 100 references indexed in Scilit:
- Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studiesInternational Journal of Epidemiology, 2010
- Quality of systematic reviews in pediatric oncology – A systematic reviewCancer Treatment Reviews, 2009
- AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviewsJournal of Clinical Epidemiology, 2009
- A Re-Evaluation of Random-Effects Meta-AnalysisJournal of the Royal Statistical Society Series A: Statistics in Society, 2008
- Arcsine test for publication bias in meta‐analyses with binary outcomesStatistics in Medicine, 2007
- A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpointsStatistics in Medicine, 2005
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986